Get the Stockscreener App
303.82
6.59%
18.79
Bio Rad Laboratories Inc stock is traded at $303.82, with a volume of 781.32K.
It is up +6.59% in the last 24 hours and up +23.77% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$285.03
Open:
$289.46
24h Volume:
781.32K
Relative Volume:
2.37
Market Cap:
$6.68B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-11.12
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
+6.36%
1M Performance:
+23.77%
6M Performance:
+8.48%
1Y Performance:
-2.00%
1-Day Range:
$287.31
$308.44
1-Week Range:
$282.00
$308.44
52-Week Range:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
303.82 | 7.70B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
132.59 | 226.73B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
106.17 | 152.69B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.22 | 145.89B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.71 | 118.91B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
81.83 | 45.97B | 5.69B | 1.41B | 577.90M | 6.95 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Bio-Rad Laboratories A's 15min chart indicates bullish sentiment with expanding Bollinger Bands. - AInvest
Bio-Rad Launches EZ-Check Salmonella spp. Kit for Detection of Salmonella spp. in Food and Environmental Samples - Cambridge Network
Is this a good reentry point in Bio Rad Laboratories Inc.Quarterly Portfolio Review & Verified Technical Signals - Newser
Sentiment analysis tools applied to Bio Rad Laboratories Inc.Gap Down & High Conviction Buy Zone Picks - Newser
What earnings revisions data tells us about Bio Rad Laboratories Inc.Oil Prices & Target Return Focused Stock Picks - Newser
Applying big data sentiment scoring on Bio Rad Laboratories Inc.Inflation Watch & Expert Approved Trade Ideas - Newser
What does recent volatility data suggest for Bio Rad Laboratories Inc.July 2025 Sentiment & Technical Confirmation Alerts - Newser
Bio Rad Laboratories Inc. Reversal Rally May Surprise BearsQuarterly Portfolio Review & Technical Buy Zone Confirmation - classian.co.kr
Biosensors Market Detailed in New 2025 Research Report - openPR.com
Hemoglobinopathy Market Opportunities and Future Scope by 2032 - openPR.com
qPCR Reagents Market: Strategic Analysis and Outlook 2025–2035 - newstrail.com
Cetera Investment Advisers Boosts Holdings in Bio-Rad Laboratories, Inc. $BIO - Defense World
Bio-Rad Laboratories, Inc. $BIO Shares Bought by Cetera Investment Advisers - Defense World
News impact scoring models applied to Bio Rad Laboratories Inc.Analyst Downgrade & Stock Portfolio Risk Control - Newser
Is Bio Rad Laboratories Inc. stock ready for a breakoutIPO Watch & Weekly High Return Stock Opportunities - Newser
Automated trading signals detected on Bio Rad Laboratories Inc.Earnings Risk Summary & Reliable Trade Execution Plans - Newser
How high can Bio Rad Laboratories Inc. stock price go in 2025Portfolio Value Report & Weekly Hot Stock Watchlists - Newser
Real time social sentiment graph for Bio Rad Laboratories Inc.2025 Analyst Calls & Safe Entry Point Identification - Newser
Bio Rad Laboratories Inc. stock trend outlook and recovery path2025 Institutional Moves & Real-Time Stock Movement Alerts - Newser
Published on: 2025-08-17 08:32:41 - sisa-n.com
Bio Rad Laboratories Inc. stock volume spike explainedMarket Performance Summary & Low Drawdown Trading Techniques - Newser
Tools to assess Bio Rad Laboratories Inc.’s risk profileWeekly Trading Summary & Advanced Swing Trade Entry Alerts - Newser
Published on: 2025-08-15 20:46:50 - beatles.ru
NGS Library Preparation Kits Market Hits New High | Major Giants, Zymo Research, Bio-Rad Laboratories - newstrail.com
Will Breakout in Bio Rad Laboratories Inc. Sustain Through Next WeekWeekly Stock Recap & Community Driven Trade Alerts - sundaytimes.kr
10 Undervalued Stocks That Crushed Q2 Earnings - Morningstar
What’s next for Bio Rad Laboratories Inc. stockMarket Volume Report & Weekly High Potential Alerts - sundaytimes.kr
Can Bio Rad Laboratories Inc. sustain earnings growthEarnings Growth Report & Stepwise Entry and Exit Trade Signals - thegnnews.com
Traders Consider Averaging Down in Bio Rad Laboratories Inc.2025 Buyback Activity & Short-Term High Return Strategies - beatles.ru
Protein Chip Market Future Business Opportunities 2025-2032 | - openPR.com
Bio-Rad Laboratories: Is The Growth in Digital PCR Business Here To Stay? - Smartkarma
Epigenetics Diagnostics Market Is Going to Boom | Major Giants Illumina, Thermo Fisher, Qiagen, Bio-Rad - newstrail.com
Cell Separation Technology Market Set to Witness Significant - openPR.com
Mexico Microcarrier Market Trends and Company Analysis - GlobeNewswire
Mexico Microcarrier Market Trends and Company Analysis Report 2025-2033 Featuring BD, Thermo Fisher Scientific, Merck, Eppendorf, Danaher, Sartorius, Bio Rad, Corning, Lonza Group, Getinge - Yahoo Finance
STD Diagnostic Market Forecast and Company Analysis Report - GlobeNewswire
STD Diagnostic Market Forecast and Company Analysis Report 2025-2033 Featuring Siemens, Abbott, MedMira, QIAGEN, Danaher, F. Hoffmann-La Roche, Diasorin, BioMeriuex, Hologic, Bio-Rad Laboratories - Yahoo Finance
PNC Financial Services Group Inc. Sells 5,152 Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO) - Defense World
Is Bio Rad Laboratories Inc. stock overvalued or fairly pricedHigh Return Stock Ideas - mustnews.co.kr
Bio-Rad Laboratories shares rise 8.44% intraday after market report predicts 10.2% CAGR in molecular quality control market. - AInvest
HCS Software and Services Market Likely to Boost in Future: Bio-Rad Laboratories, Danaher Corporation - newstrail.com
Global Gene Amplification Technologies Market Is Booming So - openPR.com
How the Molecular Quality Controls Market Will Evolve by 2032 - openPR.com
Unexpected Trends Reshaping the Neuroscience Antibodies - openPR.com
Monoclonal Antibody Diagnostic Reagents Market Set to Witness - openPR.com
Bio Rad Laboratories Inc. Moves Into Bullish Territory Based on MACDBuy Alerts With Low Risk Confirmation Noted - beatles.ru
Comparing Bio Rad Laboratories Inc. in custom built stock radarsBull Market Summary and Recovery Outlook - Newser
Bio-Rad Laboratories: Macroeconomic Uncertainty And A Limited Growth Potential Give Pause - Seeking Alpha
Enzyme Linked Immunosorbent Assay Market: Analysis of Size, - openPR.com
Hemoglobin A1c Testing Devices Market to Grow at 8.8% CAGR by 2030 - openPR.com
Porphyria Treatment Market Growth in Future Scope 2025-2032 - openPR.com
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):